Share this page:

News

Swift Biosciences Launches Accel-Amplicon™ Plus Cancer Panels for Precision Medicine Initiatives

New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon

More »

Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Initiatives

New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon

More »

Swift Biosciences Launches Unique Dual Indexing Kits to improve Multiplexed Next Generation Sequencing

New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results (ANN ARBOR, Mich. – April 6, 2018) Swift Biosciences today announced the launch of its Accel-NGS® Unique Dual Indexing Kits, which deliver the power and value of high-throughput multiplexed sequencing while improving the accuracy of low frequency variant calling, such as somatic mutations, in

More »

Swift Launches Accel-Amplicon™ Custom NGS Panels, Accelerating Variant Discovery in Challenging Biological Samples

Genialis/Swift partnership delivers a complete targeted sequencing solution with intuitive analysis software (ANN ARBOR, Mich. – Oct. 12, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of its Accel-Amplicon™ Custom NGS Panels. These new panels offer a targeted DNA sequencing product that enables clinical researchers

More »

Swift Biosciences Growth Sparks Expansion into New Headquarters & First West Coast Office

Michigan company doubles size of Ann Arbor-based operations and expands to San Francisco with new commercial office space (ANN ARBOR, Mich. and SOUTH SAN FRANCISCO – October 5, 2017) Swift Biosciences, a leading provider of innovative library-prep solutions for genomic sequencing, today announced the move and expansion of their headquarters in Ann Arbor, Michigan, and the

More »

Swift Announces the Highest Throughput Single-Cell Methyl-Seq Library Preparation Method

Study published in Science magazine demonstrates how epigenetic markers can identify cell subtypes and regulatory elements that drive cellular diversity (ANN ARBOR, Mich. – August 10, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of a new single-cell methylation sequencing method based on its Accel-NGS®

More »

Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run

Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation

More »

Swift Biosciences Launches Next Phase of Company Growth and Expansion

Company completes Series D funding and adds two new directors to board. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the company for accelerated growth. The Series D round was led by Arboretum Ventures

More »

Swift Biosciences Launches New Assay for Faster, More Efficient Routine Screening of the CFTR Gene

Accel-Amplicon™ CFTR Panel presented at the 2017 American College of Medical Genetics Annual Meeting – Swift Biosciences today announced the commercial release of its Accel-Amplicon CFTR Panel. This panel will offer research laboratories a more comprehensive, next-generation sequencing (NGS)-based approach to interrogate the coding region and select introns within the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)

More »

Swift Biosciences Launches Novel Long-Insert Library Kit to Improve Data Quality on Pacific Biosciences® Sequencing Platforms

Results from Mount Sinai, Washington University, and Cold Spring Harbor Laboratories to be presented at AGBT 2017 General Meeting (ANN ARBOR, Mich. – February 14, 2017) Swift Biosciences today announced the commercial release of its Accel-NGS® XL Library Prep Kit, the fastest sequencing solution for whole genome sequencing on Pacific Biosciences (PacBio®) platforms. This library preparation

More »